Lilly(LLY) - 2024 Q3 - Earnings Call Transcript

Eli Lilly and Company (NYSE:LLY) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Joe Fletcher - Senior Vice President-Investor Relations Dave Ricks - Chief Executive Officer Lucas Montarc - Chief Scientific Officer and President, Lilly Immunology Gordon Brooks - Group VP, Controller and Corporate Strategy and Interim CFO Dan Skovronsky - Chief Scientific Officer and President-Lilly Immunology Patrik Jonsson - President-Lilly Diabetes and Obesity and Lilly USA Ilya Yuffa - ...